+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Rx/Reimbursement Adult Incontinence in Austria

  • PDF Icon

    Report

  • 19 Pages
  • March 2023
  • Region: Austria
  • Euromonitor International
  • ID: 4517577
The Österreichische Gesundheitskasse (ÖGK) (Austrian health insurance), amended and simplified the regulations for Rx/reimbursement adult incontinence products in 2021. The new rules restrict the number of products to two per day. The health insurance company states that two products per day are sufficient, as incontinence products are increasingly efficient and absorb fluid more effectively.

The analyst's Rx/Reimbursement adult incontinence in Austria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2027 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Rx/Reimbursement adult incontinence market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

RX/REIMBURSEMENT ADULT INCONTINENCE IN AUSTRIA

KEY DATA FINDINGS

2022 DEVELOPMENTS
  • New regulations restrict product amount to two per day, frustrating consumers
  • The ageing population continues to drive the demand of Rx/reimbursement adult incontinence
  • Value increases as inflation leads to heightened price points
PROSPECTS AND OPPORTUNITIES
  • The ageing population continues to boost growth across the coming years
  • Strict reimbursement rules lead to a rise in retail sales
CATEGORY DATA
  • Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2017-2022
  • Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2017-2022
  • Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2022-2027
  • Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2022-2027
TISSUE AND HYGIENE IN AUSTRIA

EXECUTIVE SUMMARY
  • Tissue and hygiene in 2022: The big picture
  • 2022 key trends
  • Competitive landscape
  • Retailing developments
What next for tissue and hygiene?
MARKET INDICATORS
  • Table 5 Birth Rates 2017-2022
  • Table 6 Infant Population 2017-2022
  • Table 7 Female Population by Age 2017-2022
  • Table 8 Total Population by Age 2017-2022
  • Table 9 Households 2017-2022
  • Table 10 Forecast Infant Population 2022-2027
  • Table 11 Forecast Female Population by Age 2022-2027
  • Table 12 Forecast Total Population by Age 2022-2027
  • Table 13 Forecast Households 2022-2027
MARKET DATA
  • Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2017-2022
  • Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2017-2022
  • Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2018-2022
  • Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2019-2022
  • Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2017-2022
  • Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2017-2022
  • Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2022
  • Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2022-2027
  • Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2022-2027
DISCLAIMER

SOURCES
  • Summary 1 Research Sources